Pharma & Biotech

The Swiss hearing solutions group Sonova is taking decisive action to refine its business focus. By announcing the sale of...

Tempus AI Inc. finds its equity trading at a critical juncture. The stock reached a new annual low of €36.80...

Bayer's ongoing corporate restructuring is encountering turbulence from two significant external forces. As geopolitical tensions flare and energy costs climb,...

Pharmaceutical giant Pfizer has announced significant progress across two distinct areas of its clinical pipeline, marking a pivotal moment in...

Mirum Pharmaceuticals is entering what could be its most transformative period. The rare disease specialist faces a packed calendar of...

Bayer AG finds itself at a confluence of strategic developments, with a new flagship location, steady share price action, and...

The stock of Redcare Pharmacy remains trapped in a pronounced and persistent downtrend, showing few signs of finding a stable...

The healthcare conglomerate Fresenius has reported a robust finish to its 2025 fiscal year, marked by significant profit growth. Despite...

The biotechnology firm Anavex Life Sciences is confronting significant operational and legal challenges following a major regulatory disappointment in Europe....

The U.S. Food and Drug Administration (FDA) has taken decisive action against ImmunityBio, issuing a formal warning letter over what...